Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 900 | 710 | 1,010 | 570 | 570 |
| TOTAL | $900 | $710 | $1,010 | $570 | $570 |
| Non-Current Assets | |||||
| PPE Net | 750 | N/A | N/A | N/A | 1,150 |
| TOTAL | $750 | $N/A | $N/A | $N/A | $1,150 |
| Total Assets | $1,650 | $710 | $1,010 | $570 | $1,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,920 | 760 | 670 | 1,400 | 1,380 |
| Accrued Expenses | 3,340 | 3,560 | 3,470 | 3,590 | 3,930 |
| Other current liabilities | 2,500 | 0 | 0 | 0 | 0 |
| TOTAL | $8,760 | $4,320 | $4,390 | $4,990 | $5,310 |
| Non-Current Liabilities | |||||
| TOTAL | $60 | $60 | $70 | $70 | $70 |
| Total Liabilities | $8,820 | $4,380 | $4,460 | $5,060 | $5,380 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| TOTAL | $76,810 | $76,760 | $75,260 | $74,770 | $74,130 |
| Total Liabilities And Equity | $85,630 | $81,140 | $79,720 | $79,830 | $79,510 |